Wednesday
SESSION 43: MANAGEMENT OF PULMONARY EMBOLISM: THE SPECTRUM AS IT EVOLVES – DRUGS, DEVICES AND SURGERY – PART 2
Moderators:Michael R. Jaff, DO  
SESSION 43 SCHEDULE
9:45 AM - 10:00 AM The SEATTLE Trial: A Breakthrough For PE Treatment?
  Presenter(s):Gregory Piazza, MD, MS  
  View Abstract      
10:00 AM - 10:10 AM What Did The SEATTLE Trial Fail To Answer?
  Presenter(s):Clifford M. Sales, MD, MBA  
  View Abstract      
10:10 AM - 10:20 AM Vortex Strategy For Massive PE
  Presenter(s):Christopher J. Kwolek, MD  
  View Abstract      
10:20 AM - 10:35 AM ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why?
  Presenter(s):Thoralf Sundt, MD  
  View Abstract      
10:35 AM - 10:45 AM What Is The Modern Algorithm For Management Of Massive And Submassive PE
  Presenter(s):Tod C. Engelhardt, MD  
  View Abstract      
10:45 AM - 11:00 AM Iliac Venous Stenosis: When To Look And When To Stent
  Presenter(s):John A. Kaufman, MD  
  View Abstract      
11:00 AM - 11:15 AM The Team Approach To PE Management: The Emergence Of National PERT Centers
  Presenter(s):Kenneth Rosenfield, MD  
  View Abstract      
11:15 AM - 11:45 AM Challenging Cases And “PERT” Decisions
  Panelist(s): Tod C. Engelhardt, MD / John A. Kaufman, MD / Christopher J. Kwolek, MD / Gregory Piazza, MD, MS / Kenneth Rosenfield, MD / Thoralf Sundt, MD  
  View Abstract      
11:45 AM - 12:00 PM Questions And Answers
12:00 PM - 1:00 PM Lunch Break
Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 43
previous next